Document is current

Any future updates will be listed below

A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy

Crossref DOI link: https://doi.org/10.1186/s12885-016-2615-4

Published Online: 2016-08-02

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark